Anavex Life Sciences shares owned by Carnegie Capital Asset Management
Quarter-by-quarter ownership of Anavex Life Sciences (AVXL) shares owned by Carnegie Capital Asset Management
from 13F filings
Historical chart of Carnegie Capital Asset Management investment in Anavex Life Sciences
Tip: Access up to 7 years of quarterly data
All positions including Anavex Life Sciences held by Carnegie Capital Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Anavex Life Sciences by Carnegie Capital Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $417k | 73k | 5.68 |
| 2024-06-30 | $310k | 73k | 4.22 |
| 2024-03-31 | $373k | 73k | 5.09 |
| 2023-12-31 | $686k | 74k | 9.31 |
| 2023-09-30 | $442k | 67k | 6.55 |
| 2023-06-30 | $553k | 68k | 8.13 |
| 2023-03-31 | $374k | 44k | 8.57 |
| 2022-12-31 | $174k | 19k | 9.26 |
More positions owned by Carnegie Capital Asset Management
View all positions for Carnegie Capital Asset Management